Nisa Investment Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-19,200
| Closed | -$1.34M | – | 2775 |
|
|
2022
Q3 | $1.34M | Buy |
19,200
+7,709
| +67% | +$538K | 0.01% | 737 |
|
|
2022
Q2 | $771K | Buy |
11,491
+8,900
| +343% | +$597K | 0.01% | 908 |
|
|
2022
Q1 | $213K | Buy |
2,591
+784
| +43% | +$64.5K | ﹤0.01% | 1352 |
|
|
2021
Q4 | $216K | Sell |
1,807
-210
| -10% | -$25.1K | ﹤0.01% | 1246 |
|
|
2021
Q3 | $357 | Buy |
2,017
+45
| +2% | +$8 | ﹤0.01% | 1224 |
|
|
2021
Q2 | $319 | Sell |
1,972
-1,350
| -41% | -$218 | ﹤0.01% | 1261 |
|
|
2021
Q1 | $569 | Hold |
3,322
| – | – | ﹤0.01% | 1132 |
|
|
2020
Q4 | $730K | Buy |
3,322
+2,122
| +177% | +$466K | ﹤0.01% | 1046 |
|
|
2020
Q3 | $199K | Buy |
1,200
+900
| +300% | +$149K | ﹤0.01% | 1312 |
|
|
2020
Q2 | $34K | Buy |
300
+80
| +36% | +$9.07K | ﹤0.01% | 1662 |
|
|
2020
Q1 | $17K | Sell |
220
-50
| -19% | -$3.86K | ﹤0.01% | 1749 |
|
|
2019
Q4 | $35K | Buy |
270
+120
| +80% | +$15.6K | ﹤0.01% | 1593 |
|
|
2019
Q3 | $12K | Hold |
150
| – | – | ﹤0.01% | 1752 |
|
|
2019
Q2 | $15K | Hold |
150
| – | – | ﹤0.01% | 1662 |
|
|
2019
Q1 | $11K | Buy |
+150
| New | +$11K | ﹤0.01% | 1731 |
|